Triple-Negative Breast Cancer (TNBC) Terminated Phase 2 Trials for RG-4733 (DB11870)

Also known as: Triple-negative Breast Cancer

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01151449Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast CancerTreatment